Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Emerging Research Fronts Comments

Return to menu of Emerging Research Fronts

ESI Special Topics, February 2006
Citing URL: http://www.esi-topics.com/erf/2006/february06-BrendanJLoftus.html

From •>>February 2006

Brendan J. Loftus answers a few questions about this month's emerging research front in field of Microbiology:

Microbiology
Article: The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans
Authors: Loftus, BJ;Fung, E;Roncaglia, P;Rowley, D;Amedeo, P;Bruno, D;Vamathevan, J;Miranda, M;Anderson, IJ;Fraser, JA;Allen, JE;Bosdet, IE;Brent, MR;Chiu, R;Doering, TL;Dontin, MJ;D'Souza, CA;Fox, DS;Grinberg, V;Fu, JM;Fukushima, M;Haas, BJ;Huang, JC;Janbon, G;Jones, SJM;Koo, HL;Krzywinski, MI;Kwon-Chung, JK;Lengeler, KB;Maiti, R;Marra, MA;Marra, RE;Mathewson, CA;Mitchell, TG;Pertea, M;Riggs, FR;Salzberg, SL;Schein, JE;Shvartsbeyn, A;Shin, H;Shumway, M;Specht, CA;Suh, BB;Tenney, A;Utterback, TR;Wickes, BL;Wortman, JR;Wye, NH;Kronstad, JW;Lodge, JK;Heitman, J;Davis, RW;Fraser, CM;Hyman, RW
Journal: SCIENCE 13 2005, 307 (5713): 1321-1324, FEB 25 2005
Addresses:
Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.
Inst Genom Res, Rockville, MD 20850 USA.
Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.
Scuola Int Super Studi Avanzati, SISSA, I-34014 Trieste, Italy.
Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada.
Washington Univ, Lab Computat Genom, St Louis, MO 63130 USA.
Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.
Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.
Childrens Hosp, Louisiana State Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70118 USA.
Childrens Hosp, Louisiana State Hlth Sci Ctr, Res Inst Children, New Orleans, LA 70118 USA.
Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA.
Inst Pasteur, Unite Mycol Mol, Paris 15, France.
NIAID, Mol Microbiol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA.
Univ Dusseldorf, Inst Mikrobiol, D-4000 Dusseldorf, Germany.
Connecticut Agr Expt Stn, New Haven, CT 06511 USA.
Boston Univ, Dept Med, Boston, MA 02118 USA.
Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.
J Craig Venter Fdn, Joint Technol Ctr, Rockville, MD 20850 USA.
May 1, 2006: This paper has also been named the New Hot Paper in Microbiology for May 2006.


ST:  Why do you think your paper is highly cited?


“Overall, the paper implies that a whole genome approach will be essential to understanding the biology of the pathogen and important in developing long term effective treatments”

Our paper is highly cited as it represents the first whole-genome view of the important emerging fungal pathogen Cryptococcus neoformans. The work, which has contributions from a wide variety of C. neoformans scientists, uncovers the blueprint of an environmental pathogen which contains niche adaptations to its external environment as well as to survival in the human host. In addition, the paper describes an unexpected complexity at the level of gene structure and gene regulation. Finally, by elucidating the genomes of two close relatives of differing virulence properties, the paper catalogs the genetic differences that may underlie these differences in pathogenicity. Overall, the paper implies that a whole genome approach will be essential to understanding the biology of the pathogen and is important in the development of long-term effective treatments.

ST:  Does it describe a new discovery or a new methodology that's useful to others?

The paper describes the entire genetic blueprint of C. neoformans, from which a number of important discoveries have been made and .which will provide a foundation and starting point for the discovery of many more. It places an essential and valuable tool in the hands of researchers studying the organism and also those studying fungal pathogens in general. Those interested in genome evolution, gene structure, and gene regulation will find much new information contained within the data emanating from the paper.

ST:  Could you summarize the significance of your paper in layman's terms?

The paper, the data underlying it, and the analyses contained therein, provide the informational blueprint of this important human pathogen. The data highlights a number of the adaptations of C. neorformans to cope with life in its external environment and the strategies it has developed to evade the immune response of the human host. These adaptations can then be compared with those of other fungal pathogens to help understand the molecular basis of pathogenicity and also to help develop broad spectrum antifungals, or conversely, pathogen-specific treatments.

ST:  How did you become involved in this research, and were there successes or failures along the way?

I became involved in this research as Cryptococcus became a targeted organism for whole genome studies by NIAID and when TIGR and Stanford were chosen as the participating centers. During the project, it was discovered that DNA from two highly related strains differing in virulence were being sequenced. This provided additional challenges in terms of separating and assembling the data from these two strains. Once completed, however, the combination of their similarity and also the differences contained between the strains, provided invaluable information regarding the genetic basis of virulence in this organism.

ST:  If applicable, what are the social or political implications of your research?

The social implications of the research are primarily that a new and valuable asset has been placed in the hands of the researchers working on this important pathogen. This greatly expands the knowledge base, attracts new researchers to the field, and will expedite ongoing work in searching for effective treatments for this important emerging fungal pathogen.End

Brendan J. Loftus, Ph.D.
Adjunct Collaborative Investigator
The Institute for Genome Research (TIGR)
Rockville, MD, USA

Return to Emerging Research Fronts | Return to Special Topics main menu
 

ESI Special Topics, February 2006
Citing URL: http://www.esi-topics.com/erf/2006/february06-BrendanJLoftus.html

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.